1. Suzuki S, Uruha A, Suzuki N, Nishino I. Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology. Autoimmun Rev. 2017; 16:693–700.
Article
2. Dubowitz V, Sewry CA, Oldfors A. Normal muscle. In : Dubowitz V, Sewry CA, Oldfors A, Lane R, editors. Muscle biopsy: a practical approach. 4th ed. London: Elsevier;2013. p. 28–54.
3. Sewry CA, Goebel HH. General pathology of muscle disease. In : Goebel HH, Sewry CA, Weller RO, editors. Muscle disease: pathology and genetics. 2nd ed. Oxford: Wiley-Blackwell;2013. p. 19–38.
4. Dubowitz V, Sewry CA, Oldfors A. Muscular dystrophies and allied disorders I: Duchenne and Becker muscular dystrophy. In : Dubowitz V, Sewry CA, Oldfors A, Lane R, editors. Muscle biopsy: a practical approach. 4th ed. London: Elsevier;2013. p. 250–275.
5. Barresi R, Brown SC. Dystrophin and its associated glycoprotein complex. In : Goebel HH, Sewry CA, Weller RO, editors. Muscle disease: pathology and genetics. 2nd ed. Oxford: Wiley-Blackwell;2013. p. 95–101.
6. Dubowitz V, Sewry CA. Muscular dystrophies and allied disorders IV: Emery-Dreifuss muscular dystrophy and similar syndromes. In : Dubowitz V, Sewry CA, Oldfors A, Lane R, editors. Muscle biopsy: a practical approach. 4th ed. London: Elsevier;2013. p. 331–344.
7. Kim DS. Diagnostic significance of immunohistochemical staining in muscular dystrophy. J Korean Neurol Assoc. 2006; 24:1–13.
8. Park YE, Shin JH, Kim HS, Lee CH, Kim DS. Characterization of congenital myopathies at a Korean neuromuscular center. Muscle Nerve. 2018; 58:235–244.
Article
9. Ryan MM, Schnell C, Strickland CD, Shield LK, Morgan G, Iannaccone ST, et al. Nemaline myopathy: a clinical study of 143 cases. Ann Neurol. 2001; 50:312–320.
Article
10. Lee JM, Lim JG, Shin JH, Park YE, Kim DS. Clinical and genetic diversity of nemaline myopathy from a single neuromuscular center in Korea. J Neurol Sci. 2017; 383:61–68.
Article
11. Wattanasirichaigoon D, Swoboda KJ, Takada F, Tong HQ, Lip V, Iannaccone ST, et al. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology. 2002; 59:613–617.
12. Park YE, Shin JH, Kang B, Lee CH, Kim DS. NEB-related core-rod myopathy with distinct clinical and pathological features. Muscle Nerve. 2016; 53:479–484.
Article
13. Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T. Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes. Neurology. 2019; 93:e298–e305.
14. Park YE, Choi YC, Bae JS, Lee CH, Kim HS, Shin JH, et al. Clinical and pathological features of Korean patients with DNM2-related centronuclear myopathy. J Clin Neurol. 2014; 10:24–31.
15. Romero NB, Laforte J. Centronuclear myopathies. In : Goebel HH, Sewry CA, Weller RO, editors. Muscle disease: pathology and genetics. 2nd ed. Oxford: Wiley-Blackwell;2013. p. 134–144.
16. Dubowitz V, Sewry CA. Myopathies with vacuoles. In : Dubowitz V, Sewry CA, Oldfors A, Lane R, editors. Muscle biopsy: a practical approach. 4th ed. London: Elsevier;2013. p. 406–422.
17. Mair D, Biskup S, Kress W, Abicht A, Brück W, Zechel S, et al. Differential diagnosis of vacuolar myopathies in the NGS era. Brain Pathol. 2020; 30:877–896.
Article
18. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975; 292:344–347.
19. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol. 1995; 38:705–713.
Article
20. Tanboon J, Nishino I. Classification of idiopathic inflammatory myopathies: pathology perspectives. Curr Opin Neurol. 2019; 32:704–714.
Article
21. Uruha A, Suzuki S, Suzuki N, Nishino I. Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1. Brain. 2016; 139(Pt 9):e50.
Article